Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines

(2017) James L. Mohler et al.   Journal of the National Comprehensive Cancer Network

The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer

(2014) J. B. Hjelmborg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

(2014) J Athene Lane et al.   LANCET ONCOLOGY

Prevalence of theHOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy

(2013) Jennifer L. Beebe-Dimmer et al.   BJU INTERNATIONAL

HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Aggressive Disease

(2013) J. S. Witte et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

(2013) V. H. Laitinen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial

(2013) Z. Chen et al.   CARCINOGENESIS

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

(2013) Shaheen Alanee et al.   Familial Cancer

GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

(2013) Elena Castro et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

(2013) Rosalind A Eeles et al.   NATURE GENETICS

Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E

(2013) Robert J. MacInnis et al.   PLoS One

Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer

(2012) J. P. Breyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)

(2012) Jianfeng Xu et al.   HUMAN GENETICS

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

(2012) C. L. Goh et al.   JOURNAL OF INTERNAL MEDICINE

Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer

(2012) M. R. Akbari et al.   JNCI-Journal of the National Cancer Institute

Germline Mutations inHOXB13and Prostate-Cancer Risk

(2012) Charles M. Ewing et al.   NEW ENGLAND JOURNAL OF MEDICINE